文献速递肺栓塞与肺血管病

艾森曼格综合征:呼吸科视角

Eisenmenger Syndrome: The Pulmonology Perspective.
PubMed 文献 · Chest · 2026-06-25

本文从呼吸科视角综述艾森曼格综合征(ES)的肺部表现及其对症状、预后和管理的影响。ES患者常见限制性通气障碍、弥散功能受损和运动不耐受,峰值氧耗是最强预后预测因子。系统性肺部评估有助于风险分层,需心脏科与呼吸科团队协作。

要点

  • ES患者常见限制性通气障碍,也可出现阻塞性缺陷和支气管高反应性。
  • 弥散功能受损与运动能力下降和生存率降低相关,峰值氧耗是 strongest 预后预测因子。
  • 长期氧疗获益有限(低氧血症主要为分流所致),监督下康复安全且可改善功能。

核心结论

  • ES是多系统疾病,肺部异常显著影响症状和预后。
  • 系统性肺部评估可优化风险分层并支持个体化支持治疗。
  • 晚期难治性ES唯一确定性选择为双侧肺或心肺移植,但结局欠佳。

研究设计与样本

  • 综述,描述ES伴随的肺部及相关方面及其对症状、预后和管理的贡献。

主要发现

  • 功能检查常见限制性模式,阻塞性缺陷和支气管高反应性可在无典型危险因素时出现。
  • 血管疾病相关弥散功能受损常见,与运动能力下降和生存率降低相关。
  • 运动不耐受反映肺血管病、分流相关低氧血症和通气/灌注不匹配的综合效应。
  • 心肺运动试验和6分钟步行试验提供预后信息,峰值氧耗为最强预测因子。
  • 显著肺动脉扩张易致原位血栓形成和压迫综合征;咯血常源于支气管,需结构化急诊路径。

临床怎么用

  • 对ES患者进行系统性肺部评估以细化风险分层。
  • 采用心肺运动试验和6分钟步行试验评估预后。
  • 咯血需按结构化急诊路径处理。
  • 监督下康复安全且可改善功能能力。
  • 晚期难治性患者考虑双侧肺或心肺移植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC IMPORTANCE: Eisenmenger syndrome (ES) is an advanced form of pulmonary arterial hypertension associated with congenital heart disease, marked by pulmonary vascular disease and right-to-left or bidirectional shunting. Although vascular remodeling is central, lung involvement is still underrecognized. REVIEW FINDINGS: This review describes pulmonary and related aspects that accompany ES and their contribution to symptoms, prognosis, and management. A restrictive pattern is common on function testing, whereas obstructive defects and bronchial hyperresponsiveness may occur even without typical risk factors. Diffusion impairment related to vascular disease is frequent and linked to reduced exercise capacity and worse survival. Exercise intolerance reflects the combined effects of pulmonary vascular disease, shunt-related hypoxemia, and ventilation-perfusion mismatch, which increase ventilatory demand, promote early anaerobic metabolism, and reduce peak oxygen uptake. Cardiopulmonary exercise testing and the 6-minute walk test provide prognostic information, with peak oxygen consumption emerging as the strongest predictor. An additional complication is marked pulmonary artery dilatation, predisposing to in situ thrombosis and compressive syndromes. Hemoptysis, often bronchial in origin, requires a structured emergency pathway. Lower respiratory tract infections are relatively common and may increase morbidity and mortality. Long-term oxygen therapy provides limited benefit because hypoxemia is mainly shunt-driven; supervised rehabilitation is safe and can improve functional capacity. In advanced disease refractory to treatment, bilateral lung or heart-lung transplantation remains the only definitive option, despite suboptimal outcomes. SUMMARY: ES is a multisystem disorder in which pulmonary abnormalities meaningfully influence symptoms and prognosis; systematic lung assessment can refine risk stratification and support individualized supportive care by integrated cardiology-pulmonology teams.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Baino B, D'Alto M, Dimopoulos K, et al. Eisenmenger Syndrome: The Pulmonology Perspective. Chest. 2026. PMID: 42341977. doi:10.1016/j.chest.2026.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。